A detailed history of Fayez Sarofim & CO transactions in Medtronic PLC stock. As of the latest transaction made, Fayez Sarofim & CO holds 32,095 shares of MDT stock, worth $2.75 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
32,095
Previous 32,095 -0.0%
Holding current value
$2.75 Million
Previous $2.53 Million 14.37%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$78.71 - $87.02 $236,129 - $261,060
3,000 Added 10.31%
32,095 $2.53 Million
Q1 2024

May 14, 2024

SELL
$82.84 - $88.09 $22,118 - $23,520
-267 Reduced 0.91%
29,095 $2.54 Million
Q4 2023

Feb 14, 2024

SELL
$69.43 - $83.43 $1.37 Million - $1.65 Million
-19,800 Reduced 40.28%
29,362 $2.42 Million
Q2 2023

Aug 14, 2023

SELL
$79.47 - $91.38 $538,806 - $619,556
-6,780 Reduced 12.12%
49,162 $4.33 Million
Q1 2023

May 11, 2023

BUY
$76.72 - $87.58 $41,198 - $47,030
537 Added 0.97%
55,942 $4.51 Million
Q4 2022

Feb 13, 2023

SELL
$76.18 - $87.74 $41,137 - $47,379
-540 Reduced 0.97%
55,405 $4.31 Million
Q3 2022

Nov 14, 2022

SELL
$80.75 - $95.31 $138,809 - $163,837
-1,719 Reduced 2.98%
55,945 $4.52 Million
Q2 2022

Aug 12, 2022

SELL
$87.4 - $113.09 $418,558 - $541,588
-4,789 Reduced 7.67%
57,664 $5.18 Million
Q1 2022

May 16, 2022

SELL
$100.58 - $112.38 $472,625 - $528,073
-4,699 Reduced 7.0%
62,453 $6.93 Million
Q4 2021

Feb 11, 2022

BUY
$99.53 - $127.75 $964,744 - $1.24 Million
9,693 Added 16.87%
67,152 $6.95 Million
Q3 2021

Nov 15, 2021

SELL
$122.75 - $135.17 $91,817 - $101,107
-748 Reduced 1.29%
57,459 $7.2 Million
Q2 2021

Aug 13, 2021

SELL
$118.19 - $131.5 $136,273 - $151,619
-1,153 Reduced 1.94%
58,207 $7.23 Million
Q1 2021

May 13, 2021

SELL
$111.18 - $119.74 $14,453 - $15,566
-130 Reduced 0.22%
59,360 $7.01 Million
Q4 2020

Feb 11, 2021

BUY
$100.57 - $117.14 $3.41 Million - $3.97 Million
33,927 Added 132.72%
59,490 $6.97 Million
Q3 2020

Nov 13, 2020

SELL
$90.13 - $108.78 $89,138 - $107,583
-989 Reduced 3.72%
25,563 $2.66 Million
Q2 2020

Aug 11, 2020

BUY
$84.11 - $103.33 $61,484 - $75,534
731 Added 2.83%
26,552 $2.43 Million
Q1 2020

May 12, 2020

BUY
$72.92 - $121.3 $34,709 - $57,738
476 Added 1.88%
25,821 $2.33 Million
Q4 2019

Feb 14, 2020

SELL
$104.49 - $114.54 $4.39 Million - $4.82 Million
-42,048 Reduced 62.39%
25,345 $2.88 Million
Q3 2019

Nov 13, 2019

BUY
$98.02 - $111.18 $67,241 - $76,269
686 Added 1.03%
67,393 $7.32 Million
Q2 2019

Aug 09, 2019

SELL
$84.15 - $99.38 $20,448 - $24,149
-243 Reduced 0.36%
66,707 $6.5 Million
Q1 2019

May 14, 2019

SELL
$82.45 - $93.79 $9,646 - $10,973
-117 Reduced 0.17%
66,950 $6.1 Million
Q4 2018

Feb 13, 2019

BUY
$85.8 - $99.49 $68,640 - $79,592
800 Added 1.21%
67,067 $6.1 Million
Q3 2018

Nov 14, 2018

SELL
$85.91 - $99.17 $85 - $99
-1 Reduced -0.0%
66,267 $6.52 Million
Q2 2018

Aug 14, 2018

BUY
$77.48 - $87.83 $23,708 - $26,875
306 Added 0.46%
66,268 $5.67 Million
Q4 2017

Feb 13, 2018

BUY
$76.93 - $83.5 $3,154 - $3,423
41 Added 0.06%
65,962 $5.33 Million
Q3 2017

Nov 08, 2017

BUY
$77.71 - $84.6 $5.12 Million - $5.58 Million
65,921
65,921 $5.13 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $114B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Fayez Sarofim & CO Portfolio

Follow Fayez Sarofim & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.